Overview
Audit of the Effect of Changing From IV to SC Administration of ESA's in Haemodialysis Patients
Status:
Completed
Completed
Trial end date:
2008-04-01
2008-04-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to audit the effects of changing all hemodialysis patients from intravenous to subcutaneous administration of ESA's, to ensure that a cost-saving is achieved and that this does not occur at the expense of anemia control. The dose changes will occur according to usual clinical care of patients and not along a protocol.Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Sir Charles Gairdner HospitalTreatments:
Darbepoetin alfa
Hematinics
Criteria
Inclusion Criteria:- On haemodialysis at a Sir Charles Gairdner Hospital Unit